表紙
市場調查報告書

臨床營養的全球市場:地區,用途,各給藥途徑的產業分析及預測 (2020年∼2026年)

Global Clinical Nutrition Market By Route of Administration By Application By Region, Industry Analysis and Forecast, 2020 - 2026

出版商 KBV Research 商品編碼 941706
出版日期 內容資訊 英文 220 Pages
訂單完成後即時交付
價格
臨床營養的全球市場:地區,用途,各給藥途徑的產業分析及預測 (2020年∼2026年) Global Clinical Nutrition Market By Route of Administration By Application By Region, Industry Analysis and Forecast, 2020 - 2026
出版日期: 2020年05月31日內容資訊: 英文 220 Pages
簡介

全球臨床營養市場規模在預測期間內預計將以6.9%的年複合成長率增長,2026年將達到447億美元。

本報告提供全球臨床營養市場的相關調查,提供市場趨勢,給藥途徑·用途·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 與市場範圍調查手法

第2章 市場概要

  • 簡介
  • 影響市場的主要原因

第3章 競爭分析

  • KBV基數矩陣
  • 最近的產業整體策略性發展
  • 主要的成功策略

第4章 市場分析:各給藥途徑

  • 口服
  • 經腸
  • 非口服

第5章 市場分析:各用途

  • 癌症
  • 神經疾病
  • 消化器官疾病
  • 代謝障礙
  • 其他

第6章 市場分析:各終端用戶

  • 成人
  • 兒童
  • 老年人

第7章 市場分析:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲
  • 南美·中東·非洲:各用途

第8章 企業簡介

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Nestle S.A.
  • Lonza Group AG
  • BASF SE
  • Ajinomoto Co. Inc.
  • Perrigo Company PLC
  • Hero Nutritionals, Inc.
目錄

Title:
Global Clinical Nutrition Market By Route of Administration (Oral, Enteral and Parenteral) By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications) By Region, Industry Analysis and Forecast, 2020 - 2026.

The Global Clinical Nutrition Market size is expected to reach $44.7 billion by 2026, rising at a market growth of 6.9% CAGR during the forecast period. Clinical nutrition is a type of pharmaceutical product that keeps patients healthy with the necessary amounts of nutrients such as proteins, vitamins, and minerals. These nutritional components help to improve metabolic functions, release, and body absorption. Nutrition offers key nutrients, such as minerals, proteins, and vitamins. In addition, nutrition is an amalgamation of science and medicine that offers a wide range of nutrient medicines.

In treating the conditions associated with chronic diet malnutrition & treatments, clinical nutrition is being used extensively. Additionally, dietary improvements help people to get a correct diet and body balance. Clinical nutrition works in acute and ambulatory medical conditions including heart recovery, renal dialysis, diabetes, pediatrics, nutrition care, cancer, trauma, and treatments at wellness centers.

In most of the nations, it has also been shown that health spending tends to rise faster than economic growth, continuing a pattern that has been established across the decades. Subsequently, due to their broad applicability, the market is expected to grow higher as the spending in healthcare among the major countries of the world increases. Governments around the world, including private foundations and the international community, are offering many financial opportunities for clinical nutrition. National health institutes, the U.S Department of Agriculture, the Robert Woods Johnson Foundation, and the Nestle Foundation are major financing organizations.

Recent years have seen a high focus among businesses and clinics on fitness and wellness, aging, and disease prevention. In the presence of a variety of chronic disorders, such as coronary heart disease, ischemic stroke, diabetes, and some cancer indications, preventive medical treatment is successful and has been widely embraced by hospitals and clinics in North America. Furthermore, health expenditure continues to grow faster than economic growth in most countries. The emergence of fair, responsive, and efficient health services throughout North American countries has also led to the highest share of GDP for healthcare spending.

Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The major strategies followed by the market participants are Acquisition and Product Launches. Based on the Analysis presented in the Cardinal matrix, BASF SE, Pfizer, Inc., Nestle S.A., and Abbott Laboratories are the forerunners in the Clinical Nutrition Market. Companies such as Lonza Group AG, Ajinomoto Co., Inc., B. Braun Melsungen AG, Baxter International, Inc., and Perrigo Company PLC are some of the key innovators in the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.

Recent strategies deployed in Clinical Nutrition Market

Partnerships, Collaborations, and Agreements:

Dec-2019: BASF Nutrition & Health announced its collaboration with Idogen, a Swiss pharmaceutical company. Following the collaboration, the former company launched an omega 3 fatty acid solution, Hepacor, in the European market. The solution helps patients manage Non-Alcoholic Fatty Liver Disease (NAFLD) by elevating healthy lipids in the bloodstream.

Sep-2019: B. Braun collaborated with Smartfish AS, a nutrition-based company. The collaboration was focused on securely launching the latter company's medical nutrition product Remune.

May-2019: Nestle Health Science came into partnership with Amazentis, a pioneer in science-driven nutritional health. The partnership was focused on developing its new cellular nutrient Urolithin A. Also, the two companies were aimed to conduct a joint research program for expanding applications of Urolithin A, a pioneering cellular nutrient that supports mitochondrial health into new consumer health and medical areas.

May-2019: BASF partnered with Glycosyn, a biotechnology company. The partnership was aimed to develop and commercialize human milk oligosaccharides (HMOs) for broad use in dietary supplements, functional nutrition, and medical food.

Feb-2019: Lonza Consumer Health & Nutrition teamed up with DuPont Nutrition & Health. Following the collaboration, the companies were aimed to manufacture and supply human milk oligosaccharides (HMO).

Feb-2019: Ajinomoto's subsidiary Cambrooke Therapeutics signed partnership agreement with Trovita Health Science, a specialty medical nutrition company. The partnership was focused on joint marketing and development of ENU Nutrition meal replacement shakes.

Acquisition and Mergers:

Nov-2017: Ajinomoto Co., Inc. announced the acquisition of Cambrooke Therapeutics, Inc., a global leader and innovator in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy. With this acquisition, Cambrooke got access to Ajinomoto's global nutrition and ingredient sciences expertise, as well as proven flavor and texture-enhancing R&D capabilities.

Jul-2017: Lonza Group took over Capsugel S.A. from KKR. The acquisition accelerated the company's existing product offerings and enabled the company to strengthen its business in the pharma and consumer healthcare and nutrition industries.

Jan-2017: Abbott acquired St. Jude Medical, Inc., a medical device company. The acquisition expanded opportunities for Abbott's future growth and helped the company in developing a strong, diverse portfolio of devices, diagnostics, nutrition, and branded generic pharmaceuticals.

Sep-2016: Lonza acquired Benicia, a CA-based InterHealth Nutraceuticals, nutritional ingredient research, development, and manufacture company. The acquisition broadened Lonza's nutritional ingredient portfolio and strengthened its position in the dietary supplement market.

Jan-2016: Pfizer completed the acquisition of Sirio Pharma's wholly-owned subsidiary, Treerly Health Co., a women's nutritional healthcare brand in China. The acquisition broadened Pfizer Consumer Healthcare's products in China with OTC dietary supplements.

Product Launches and Product Expansions:

Oct-2019: Lonza launched MuscleGuard formulation, a unique patent-pending ingredient combination. The combination comprised of a precise and clinically-studied ratio of four nutrients; Lonza's Carnipure L-Carnitine, Creatine, and Leucine with vitamin D. MuscleGuard formulation deliver positive results for sports performance and recovery through a significant increase in muscle strength, mass, and activity.

Aug-2019: Baxter International introduced the Olimel N12, the new addition to the company's olive oil-based parenteral nutrition (PN) triple-chamber bag portfolio. Olimel N12 combined a high protein formulation with low glucose content, resulting in the lowest energy to protein ratio currently available in a standardized, triple-chamber bag.

Jul-2019: Baxter International announced the European launch of Finomel, a ready-to-use triple-chamber bag for parenteral nutrition (PN). Finomel offers healthcare providers with additional options to meet adult patients' diverse nutritional needs.

Scope of the Study

Market Segmentation:

By Route of Administration

  • Oral
  • Enteral and
  • Parenteral

By Application

  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Metabolic Disorders and
  • Other Applications

By Geography

  • North America

US

Canada

Mexico

Rest of North America

  • Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

  • Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

  • LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Nestle S.A.
  • Lonza Group AG
  • BASF SE
  • Ajinomoto Co., Inc.
  • Perrigo Company PLC
  • Hero Nutritionals, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Clinical Nutrition Market, by Route of Administration
    • 1.4.2 Global Clinical Nutrition Market, by Application
    • 1.4.3 Global Clinical Nutrition Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Mergers & Acquisitions
    • 3.2.4 Geographical Expansions
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Jan - 2019, Dec) Leading Players
    • 3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2016, Mar - 2019, Oct) Leading Players

Chapter 4. Global Clinical Nutrition Market by Route Of Administration

  • 4.1 Global Oral Market by Region
  • 4.2 Global Enteral Market by Region
  • 4.3 Global Parenteral Market by Region

Chapter 5. Global Clinical Nutrition Market by Application

  • 5.1 Global Cancer Market by Region
  • 5.2 Global Neurological Diseases Market by Region
  • 5.3 Global Gastrointestinal Disorders Market by Region
  • 5.4 Global Metabolic Disorders Market by Region
  • 5.5 Global Other Applications Market by Region

Chapter 6. Global Clinical Nutrition Market by End User

  • 6.1 Global Adults Clinical Nutrition Market by Region
  • 6.2 Global Pediatric Market by Region
  • 6.3 Global Geriatric Market by Region

Chapter 7. Global Clinical Nutrition Market by Region

  • 7.1 North America Clinical Nutrition Market
    • 7.1.1 North America Clinical Nutrition Market by Route Of Administration
      • 7.1.1.1 North America Oral Market by Country
      • 7.1.1.2 North America Enteral Market by Country
      • 7.1.1.3 North America Parenteral Market by Country
    • 7.1.2 North America Clinical Nutrition Market by Application
      • 7.1.2.1 North America Cancer Market by Country
      • 7.1.2.2 North America Neurological Diseases Market by Country
      • 7.1.2.3 North America Gastrointestinal Disorders Market by Country
      • 7.1.2.4 North America Metabolic Disorders Market by Country
      • 7.1.2.5 North America Other Applications Market by Country
    • 7.1.3 North America Clinical Nutrition Market by End User
      • 7.1.3.1 North America Adults Clinical Nutrition Market by Country
      • 7.1.3.2 North America Pediatric Market by Country
      • 7.1.3.3 North America Geriatric Market by Country
    • 7.1.4 North America Clinical Nutrition Market by Country
      • 7.1.4.1 US Clinical Nutrition Market
        • 7.1.4.1.1 US Clinical Nutrition Market by Route Of Administration
        • 7.1.4.1.2 US Clinical Nutrition Market by Application
        • 7.1.4.1.3 US Clinical Nutrition Market by End User
      • 7.1.4.2 Canada Clinical Nutrition Market
        • 7.1.4.2.1 Canada Clinical Nutrition Market by Route Of Administration
        • 7.1.4.2.2 Canada Clinical Nutrition Market by Application
        • 7.1.4.2.3 Canada Clinical Nutrition Market by End User
      • 7.1.4.3 Mexico Clinical Nutrition Market
        • 7.1.4.3.1 Mexico Clinical Nutrition Market by Route Of Administration
        • 7.1.4.3.2 Mexico Clinical Nutrition Market by Application
        • 7.1.4.3.3 Mexico Clinical Nutrition Market by End User
      • 7.1.4.4 Rest of North America Clinical Nutrition Market
        • 7.1.4.4.1 Rest of North America Clinical Nutrition Market by Route Of Administration
        • 7.1.4.4.2 Rest of North America Clinical Nutrition Market by Application
        • 7.1.4.4.3 Rest of North America Clinical Nutrition Market by End User
  • 7.2 Europe Clinical Nutrition Market
    • 7.2.1 Europe Clinical Nutrition Market by Route Of Administration
      • 7.2.1.1 Europe Oral Market by Country
      • 7.2.1.2 Europe Enteral Market by Country
      • 7.2.1.3 Europe Parenteral Market by Country
    • 7.2.2 Europe Clinical Nutrition Market by Application
      • 7.2.2.1 Europe Cancer Market by Country
      • 7.2.2.2 Europe Neurological Diseases Market by Country
      • 7.2.2.3 Europe Gastrointestinal Disorders Market by Country
      • 7.2.2.4 Europe Metabolic Disorders Market by Country
      • 7.2.2.5 Europe Other Applications Market by Country
    • 7.2.3 Europe Clinical Nutrition Market by End User
      • 7.2.3.1 Europe Adults Clinical Nutrition Market by Country
      • 7.2.3.2 Europe Pediatric Market by Country
      • 7.2.3.3 Europe Geriatric Market by Country
    • 7.2.4 Europe Clinical Nutrition Market by Country
      • 7.2.4.1 Germany Clinical Nutrition Market
        • 7.2.4.1.1 Germany Clinical Nutrition Market by Route Of Administration
        • 7.2.4.1.2 Germany Clinical Nutrition Market by Application
        • 7.2.4.1.3 Germany Clinical Nutrition Market by End User
      • 7.2.4.2 UK Clinical Nutrition Market
        • 7.2.4.2.1 UK Clinical Nutrition Market by Route Of Administration
        • 7.2.4.2.2 UK Clinical Nutrition Market by Application
        • 7.2.4.2.3 UK Clinical Nutrition Market by End User
      • 7.2.4.3 France Clinical Nutrition Market
        • 7.2.4.3.1 France Clinical Nutrition Market by Route Of Administration
        • 7.2.4.3.2 France Clinical Nutrition Market by Application
        • 7.2.4.3.3 France Clinical Nutrition Market by End User
      • 7.2.4.4 Russia Clinical Nutrition Market
        • 7.2.4.4.1 Russia Clinical Nutrition Market by Route Of Administration
        • 7.2.4.4.2 Russia Clinical Nutrition Market by Application
        • 7.2.4.4.3 Russia Clinical Nutrition Market by End User
      • 7.2.4.5 Spain Clinical Nutrition Market
        • 7.2.4.5.1 Spain Clinical Nutrition Market by Route Of Administration
        • 7.2.4.5.2 Spain Clinical Nutrition Market by Application
        • 7.2.4.5.3 Spain Clinical Nutrition Market by End User
      • 7.2.4.6 Italy Clinical Nutrition Market
        • 7.2.4.6.1 Italy Clinical Nutrition Market by Route Of Administration
        • 7.2.4.6.2 Italy Clinical Nutrition Market by Application
        • 7.2.4.6.3 Italy Clinical Nutrition Market by End User
      • 7.2.4.7 Rest of Europe Clinical Nutrition Market
        • 7.2.4.7.1 Rest of Europe Clinical Nutrition Market by Route Of Administration
        • 7.2.4.7.2 Rest of Europe Clinical Nutrition Market by Application
        • 7.2.4.7.3 Rest of Europe Clinical Nutrition Market by End User
  • 7.3 Asia Pacific Clinical Nutrition Market
    • 7.3.1 Asia Pacific Clinical Nutrition Market by Route Of Administration
      • 7.3.1.1 Asia Pacific Oral Market by Country
      • 7.3.1.2 Asia Pacific Enteral Market by Country
      • 7.3.1.3 Asia Pacific Parenteral Market by Country
    • 7.3.2 Asia Pacific Clinical Nutrition Market by Application
      • 7.3.2.1 Asia Pacific Cancer Market by Country
      • 7.3.2.2 Asia Pacific Neurological Diseases Market by Country
      • 7.3.2.3 Asia Pacific Gastrointestinal Disorders Market by Country
      • 7.3.2.4 Asia Pacific Metabolic Disorders Market by Country
      • 7.3.2.5 Asia Pacific Other Applications Market by Country
    • 7.3.3 Asia Pacific Clinical Nutrition Market by End User
      • 7.3.3.1 Asia Pacific Pediatric Market by Country
      • 7.3.3.2 Asia Pacific Geriatric Market by Country
    • 7.3.4 Asia Pacific Clinical Nutrition Market by Country
      • 7.3.4.1 China Clinical Nutrition Market
        • 7.3.4.1.1 China Clinical Nutrition Market by Route Of Administration
        • 7.3.4.1.2 China Clinical Nutrition Market by Application
        • 7.3.4.1.3 China Clinical Nutrition Market by End User
      • 7.3.4.2 Japan Clinical Nutrition Market
        • 7.3.4.2.1 Japan Clinical Nutrition Market by Route Of Administration
        • 7.3.4.2.2 Japan Clinical Nutrition Market by Application
        • 7.3.4.2.3 Japan Clinical Nutrition Market by End User
      • 7.3.4.3 India Clinical Nutrition Market
        • 7.3.4.3.1 India Clinical Nutrition Market by Route Of Administration
        • 7.3.4.3.2 India Clinical Nutrition Market by Application
        • 7.3.4.3.3 India Clinical Nutrition Market by End User
      • 7.3.4.4 South Korea Clinical Nutrition Market
        • 7.3.4.4.1 South Korea Clinical Nutrition Market by Route Of Administration
        • 7.3.4.4.2 South Korea Clinical Nutrition Market by Application
        • 7.3.4.4.3 South Korea Clinical Nutrition Market by End User
      • 7.3.4.5 Singapore Clinical Nutrition Market
        • 7.3.4.5.1 Singapore Clinical Nutrition Market by Route Of Administration
        • 7.3.4.5.2 Singapore Clinical Nutrition Market by Application
        • 7.3.4.5.3 Singapore Clinical Nutrition Market by End User
      • 7.3.4.6 Malaysia Clinical Nutrition Market
        • 7.3.4.6.1 Malaysia Clinical Nutrition Market by Route Of Administration
        • 7.3.4.6.2 Malaysia Clinical Nutrition Market by Application
        • 7.3.4.6.3 Malaysia Clinical Nutrition Market by End User
      • 7.3.4.7 Rest of Asia Pacific Clinical Nutrition Market
        • 7.3.4.7.1 Rest of Asia Pacific Clinical Nutrition Market by Route Of Administration
        • 7.3.4.7.2 Rest of Asia Pacific Clinical Nutrition Market by Application
        • 7.3.4.7.3 Rest of Asia Pacific Clinical Nutrition Market by End User
  • 7.4 LAMEA Clinical Nutrition Market
    • 7.4.1 LAMEA Clinical Nutrition Market by Route Of Administration
      • 7.4.1.1 LAMEA Oral Market by Country
      • 7.4.1.2 LAMEA Enteral Market by Country
      • 7.4.1.3 LAMEA Parenteral Market by Country
  • 7.5 LAMEA Clinical Nutrition Market by Application
      • 7.5.1.1 LAMEA Cancer Market by Country
      • 7.5.1.2 LAMEA Neurological Diseases Market by Country
      • 7.5.1.3 LAMEA Gastrointestinal Disorders Market by Country
      • 7.5.1.4 LAMEA Metabolic Disorders Market by Country
      • 7.5.1.5 LAMEA Other Applications Market by Country
    • 7.5.2 LAMEA Clinical Nutrition Market by End User
      • 7.5.2.1 LAMEA Adults Clinical Nutrition Market by Country
      • 7.5.2.2 LAMEA Pediatric Market by Country
      • 7.5.2.3 LAMEA Geriatric Market by Country
    • 7.5.3 LAMEA Clinical Nutrition Market by Country
      • 7.5.3.1 Brazil Clinical Nutrition Market
        • 7.5.3.1.1 Brazil Clinical Nutrition Market by Route Of Administration
        • 7.5.3.1.2 Brazil Clinical Nutrition Market by Application
        • 7.5.3.1.3 Brazil Clinical Nutrition Market by End User
      • 7.5.3.2 Argentina Clinical Nutrition Market
        • 7.5.3.2.1 Argentina Clinical Nutrition Market by Route Of Administration
        • 7.5.3.2.2 Argentina Clinical Nutrition Market by Application
        • 7.5.3.2.3 Argentina Clinical Nutrition Market by End User
      • 7.5.3.3 UAE Clinical Nutrition Market
        • 7.5.3.3.1 UAE Clinical Nutrition Market by Route Of Administration
        • 7.5.3.3.2 UAE Clinical Nutrition Market by Application
        • 7.5.3.3.3 UAE Clinical Nutrition Market by End User
      • 7.5.3.4 Saudi Arabia Clinical Nutrition Market
        • 7.5.3.4.1 Saudi Arabia Clinical Nutrition Market by Route Of Administration
        • 7.5.3.4.2 Saudi Arabia Clinical Nutrition Market by Application
        • 7.5.3.4.3 Saudi Arabia Clinical Nutrition Market by End User
      • 7.5.3.5 South Africa Clinical Nutrition Market
        • 7.5.3.5.1 South Africa Clinical Nutrition Market by Route Of Administration
        • 7.5.3.5.2 South Africa Clinical Nutrition Market by Application
        • 7.5.3.5.3 South Africa Clinical Nutrition Market by End User
      • 7.5.3.6 Nigeria Clinical Nutrition Market
        • 7.5.3.6.1 Nigeria Clinical Nutrition Market by Application
        • 7.5.3.6.2 Nigeria Clinical Nutrition Market by End User
      • 7.5.3.7 Rest of LAMEA Clinical Nutrition Market
        • 7.5.3.7.1 Rest of LAMEA Clinical Nutrition Market by Route Of Administration
        • 7.5.3.7.2 Rest of LAMEA Clinical Nutrition Market by Application
        • 7.5.3.7.3 Rest of LAMEA Clinical Nutrition Market by End User

Chapter 8. Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Acquisition and Mergers:
      • 8.1.5.2 Product Launches and Product Expansions:
  • 8.2 B. Braun Melsungen AG
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Product Launches and Product Expansions:
      • 8.2.5.2 Partnerships, Collaborations, and Agreements:
  • 8.3 Baxter International, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Product Launches and Product Expansions:
  • 8.4 Pfizer, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Segmental and Regional Analysis
    • 8.4.3 Research & Development Expense
    • 8.4.4 Recent strategies and developments:
      • 8.4.4.1 Acquisition and Mergers:
  • 8.5 Nestle S.A.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research& Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
      • 8.5.5.2 Product Launches and Product Expansions:
      • 8.5.5.3 Geographical Expansions:
  • 8.6 Lonza Group AG
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
      • 8.6.5.2 Product Launches and Product Expansions:
      • 8.6.5.3 Acquisition and Mergers:
  • 8.7 BASF SE
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Partnerships, Collaborations, and Agreements:
  • 8.8 Ajinomoto Co., Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental & Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Partnerships, Collaborations, and Agreements:
      • 8.8.5.2 Acquisition and Mergers:
  • 8.9 Perrigo Company PLC
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
  • 8.1 Hero Nutritionals, Inc.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 2. GLOBAL CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 3. PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- CLINICAL NUTRITION MARKET
  • TABLE 4. PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- CLINICAL NUTRITION MARKET
  • TABLE 5. MERGERS & ACQUISITIONS - CLINICAL NUTRITION MARKET
  • TABLE 6. GEOGRAPHICAL EXPANSIONS - CLINICAL NUTRITION MARKET
  • TABLE 7. GLOBAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 8. GLOBAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 9. GLOBAL ORAL MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 10. GLOBAL ORAL MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 11. GLOBAL ENTERAL MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 12. GLOBAL ENTERAL MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 13. GLOBAL PARENTERAL MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 14. GLOBAL PARENTERAL MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 15. GLOBAL CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 16. GLOBAL CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 17. GLOBAL CANCER MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 18. GLOBAL CANCER MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 19. GLOBAL NEUROLOGICAL DISEASES MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 20. GLOBAL NEUROLOGICAL DISEASES MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 21. GLOBAL GASTROINTESTINAL DISORDERS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 22. GLOBAL GASTROINTESTINAL DISORDERS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 23. GLOBAL METABOLIC DISORDERS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 24. GLOBAL METABOLIC DISORDERS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 25. GLOBAL OTHER APPLICATIONS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 26. GLOBAL OTHER APPLICATIONS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 27. GLOBAL CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 28. GLOBAL CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 29. GLOBAL ADULTS CLINICAL NUTRITION MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 30. GLOBAL ADULTS CLINICAL NUTRITION MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 31. GLOBAL PEDIATRIC MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 32. GLOBAL PEDIATRIC MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 33. GLOBAL GERIATRIC MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 34. GLOBAL GERIATRIC MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 35. GLOBAL CLINICAL NUTRITION MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 36. GLOBAL CLINICAL NUTRITION MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 37. NORTH AMERICA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 38. NORTH AMERICA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 39. NORTH AMERICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 40. NORTH AMERICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 41. NORTH AMERICA ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 42. NORTH AMERICA ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 43. NORTH AMERICA ENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 44. NORTH AMERICA ENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 45. NORTH AMERICA PARENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 46. NORTH AMERICA PARENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 47. NORTH AMERICA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 48. NORTH AMERICA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 49. NORTH AMERICA CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 50. NORTH AMERICA CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 51. NORTH AMERICA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 52. NORTH AMERICA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 53. NORTH AMERICA GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 54. NORTH AMERICA GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 55. NORTH AMERICA METABOLIC DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 56. NORTH AMERICA METABOLIC DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 57. NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 58. NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 59. NORTH AMERICA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 60. NORTH AMERICA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 61. NORTH AMERICA ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 62. NORTH AMERICA ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 63. NORTH AMERICA PEDIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 64. NORTH AMERICA PEDIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 65. NORTH AMERICA GERIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 66. NORTH AMERICA GERIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 67. NORTH AMERICA CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 68. NORTH AMERICA CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 69. US CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 70. US CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 71. US CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 72. US CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 73. US CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 74. US CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 75. US CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 76. US CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 77. CANADA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 78. CANADA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 79. CANADA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 80. CANADA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 81. CANADA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 82. CANADA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 83. CANADA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 84. CANADA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 85. MEXICO CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 86. MEXICO CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 87. MEXICO CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 88. MEXICO CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 89. MEXICO CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 90. MEXICO CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 91. MEXICO CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 92. MEXICO CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 93. REST OF NORTH AMERICA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 94. REST OF NORTH AMERICA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 95. REST OF NORTH AMERICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 96. REST OF NORTH AMERICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 97. REST OF NORTH AMERICA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 98. REST OF NORTH AMERICA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 99. REST OF NORTH AMERICA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 100. REST OF NORTH AMERICA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 101. EUROPE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 102. EUROPE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 103. EUROPE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 104. EUROPE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 105. EUROPE ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 106. EUROPE ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 107. EUROPE ENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 108. EUROPE ENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 109. EUROPE PARENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 110. EUROPE PARENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 111. EUROPE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 112. EUROPE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 113. EUROPE CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 114. EUROPE CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 115. EUROPE NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 116. EUROPE NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 117. EUROPE GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 118. EUROPE GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 119. EUROPE METABOLIC DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 120. EUROPE METABOLIC DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 121. EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 122. EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 123. EUROPE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 124. EUROPE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 125. EUROPE ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 126. EUROPE ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 127. EUROPE PEDIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 128. EUROPE PEDIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 129. EUROPE GERIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 130. EUROPE GERIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 131. EUROPE CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 132. EUROPE CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 133. GERMANY CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 134. GERMANY CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 135. GERMANY CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 136. GERMANY CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 137. GERMANY CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 138. GERMANY CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 139. GERMANY CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 140. GERMANY CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 141. UK CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 142. UK CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 143. UK CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 144. UK CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 145. UK CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 146. UK CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 147. UK CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 148. UK CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 149. FRANCE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 150. FRANCE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 151. FRANCE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 152. FRANCE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 153. FRANCE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 154. FRANCE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 155. FRANCE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 156. FRANCE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 157. RUSSIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 158. RUSSIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 159. RUSSIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 160. RUSSIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 161. RUSSIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 162. RUSSIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 163. RUSSIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 164. RUSSIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 165. SPAIN CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 166. SPAIN CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 167. SPAIN CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 168. SPAIN CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 169. SPAIN CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 170. SPAIN CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 171. SPAIN CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 172. SPAIN CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 173. ITALY CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 174. ITALY CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 175. ITALY CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 176. ITALY CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 177. ITALY CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 178. ITALY CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 179. ITALY CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 180. ITALY CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 181. REST OF EUROPE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 182. REST OF EUROPE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 183. REST OF EUROPE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 184. REST OF EUROPE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 185. REST OF EUROPE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 186. REST OF EUROPE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 187. REST OF EUROPE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 188. REST OF EUROPE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 189. ASIA PACIFIC CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 190. ASIA PACIFIC CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 191. ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 192. ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 193. ASIA PACIFIC ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 194. ASIA PACIFIC ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 195. ASIA PACIFIC ENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 196. ASIA PACIFIC ENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 197. ASIA PACIFIC PARENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 198. ASIA PACIFIC PARENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 199. ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 200. ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 201. ASIA PACIFIC CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 202. ASIA PACIFIC CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 203. ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 204. ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 205. ASIA PACIFIC GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 206. ASIA PACIFIC GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 207. ASIA PACIFIC METABOLIC DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 208. ASIA PACIFIC METABOLIC DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 209. ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 210. ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 211. ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 212. ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 213. ASIA PACIFIC ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 214. ASIA PACIFIC ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 215. ASIA PACIFIC PEDIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 216. ASIA PACIFIC PEDIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 217. ASIA PACIFIC GERIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 218. ASIA PACIFIC GERIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 219. ASIA PACIFIC CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 220. ASIA PACIFIC CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 221. CHINA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 222. CHINA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 223. CHINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 224. CHINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 225. CHINA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 226. CHINA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 227. CHINA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 228. CHINA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 229. JAPAN CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 230. JAPAN CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 231. JAPAN CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 232. JAPAN CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 233. JAPAN CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 234. JAPAN CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 235. JAPAN CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 236. JAPAN CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 237. INDIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 238. INDIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 239. INDIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 240. INDIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 241. INDIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 242. INDIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 243. INDIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 244. INDIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 245. SOUTH KOREA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 246. SOUTH KOREA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 247. SOUTH KOREA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 248. SOUTH KOREA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 249. SOUTH KOREA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 250. SOUTH KOREA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 251. SOUTH KOREA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 252. SOUTH KOREA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 253. SINGAPORE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 254. SINGAPORE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 255. SINGAPORE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 256. SINGAPORE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 257. SINGAPORE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 258. SINGAPORE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 259. SINGAPORE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 260. SINGAPORE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 261. MALAYSIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 262. MALAYSIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 263. MALAYSIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 264. MALAYSIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 265. MALAYSIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 266. MALAYSIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 267. MALAYSIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 268. MALAYSIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 269. REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 270. REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 271. REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 272. REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 273. REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 274. REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 275. REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 276. REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 277. LAMEA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 278. LAMEA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 279. LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 280. LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 281. LAMEA ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 282. LAMEA ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 283. LAMEA ENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 284. LAMEA ENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 285. LAMEA PARENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 286. LAMEA PARENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 287. LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 288. LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 289. LAMEA CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 290. LAMEA CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 291. LAMEA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 292. LAMEA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 293. LAMEA GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 294. LAMEA GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 295. LAMEA METABOLIC DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 296. LAMEA METABOLIC DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 297. LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 298. LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 299. LAMEA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 300. LAMEA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 301. LAMEA ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 302. LAMEA ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 303. LAMEA PEDIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 304. LAMEA PEDIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 305. LAMEA GERIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 306. LAMEA GERIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 307. LAMEA CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 308. LAMEA CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 309. BRAZIL CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 310. BRAZIL CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 311. BRAZIL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 312. BRAZIL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 313. BRAZIL CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 314. BRAZIL CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 315. BRAZIL CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 316. BRAZIL CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 317. ARGENTINA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 318. ARGENTINA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 319. ARGENTINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 320. ARGENTINA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 321. ARGENTINA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 322. ARGENTINA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 323. ARGENTINA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 324. ARGENTINA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 325. UAE CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 326. UAE CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 327. UAE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 328. UAE CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 329. UAE CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 330. UAE CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 331. UAE CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 332. UAE CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 333. SAUDI ARABIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 334. SAUDI ARABIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 335. SAUDI ARABIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 336. SAUDI ARABIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 337. SAUDI ARABIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 338. SAUDI ARABIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 339. SAUDI ARABIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 340. SAUDI ARABIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 341. SOUTH AFRICA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 342. SOUTH AFRICA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 343. SOUTH AFRICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 344. SOUTH AFRICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 345. SOUTH AFRICA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 346. SOUTH AFRICA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 347. SOUTH AFRICA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 348. SOUTH AFRICA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 349. NIGERIA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 350. NIGERIA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 351. NIGERIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 352. NIGERIA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 353. NIGERIA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 354. NIGERIA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 355. NIGERIA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 356. NIGERIA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 357. REST OF LAMEA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 358. REST OF LAMEA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 359. REST OF LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 360. REST OF LAMEA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 361. REST OF LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 362. REST OF LAMEA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 363. REST OF LAMEA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 364. REST OF LAMEA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 365. KEY INFORMATION - ABBOTT LABORATORIES
  • TABLE 366. KEY INFORMATION - B. BRAUN MELSUNGEN AG
  • TABLE 367. KEY INFORMATION - BAXTER INTERNATIONAL, INC.
  • TABLE 368. KEY INFORMATION - PFIZER, INC.
  • TABLE 369. KEY INFORMATION - NESTLE S.A.
  • TABLE 370. KEY INFORMATION - LONZA GROUP AG
  • TABLE 371. KEY INFORMATION - BASF SE
  • TABLE 372. KEY INFORMATION -AJINOMOTO CO., INC.
  • TABLE 373. KEY INFORMATION - PERRIGO COMPANY PLC
  • TABLE 374. KEY INFORMATION - HERO NUTRITIONALS, INC.

LIST OF FIGURES

  • FIG 1. METHODOLOGY FOR THE RESEARCH
  • FIG 2. KBV CARDINAL MATRIX
  • FIG 3. KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
  • FIG 4. KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS : 2016, JAN - 2019, DEC) LEADING PLAYERS
  • FIG 5. KEY STRATEGIC MOVE: (PRODUCT LAUNCHES AND PRODUCT EXPANSIONS : 2016, MAR - 2019, OCT) LEADING PLAYERS
  • FIG 6. RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
  • FIG 7. RECENT STRATEGIES AND DEVELOPMENTS: B. BRAUN MELSUNGEN AG
  • FIG 8. RECENT STRATEGIES AND DEVELOPMENTS: NESTLE S.A.
  • FIG 9. RECENT STRATEGIES AND DEVELOPMENTS: LONZA GROUP AG
  • FIG 10. RECENT STRATEGIES AND DEVELOPMENTS: AJINOMOTO CO., INC.